Date published: 2026-4-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

SDZ NKT 343 (CAS 180046-99-5)

0.0(0)
Write a reviewAsk a question

Alternate Names:
1-[[(2-Nitrophenyl)amino]carbonyl]-L-prolyl-N-methyl-3-(2-naphthalenyl)-N-(phenylmethyl)-L-alaninamide
Application:
SDZ NKT 343 is a human tachykinin NK1 antagonist receptor
CAS Number:
180046-99-5
Molecular Weight:
579.65
Molecular Formula:
C33H33N5O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

SDZ NKT 343 is a highly selective human tachykinin NK1 antagonist receptor(IC50 values are 0.62 and 451 nM for human and rat receptors respectively) that displays > 130-fold selectivity over human NK2 and NK3 receptors. SDZ NKT 343 potently antagonizes SP-induced Ca2+ efflux in vitro.


SDZ NKT 343 (CAS 180046-99-5) References

Walpole et al (1998) Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. Br.J.Pharmacol. 124 83. Walpole et al (1998) 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N-methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models. J.Med.Chem. 41 3159. Campbell et al (1998) Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience. 87 527.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

SDZ NKT 343, 10 mg

sc-204274
10 mg
$255.00